Picture of Everest Medicines logo

1952 Everest Medicines Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapMomentum Trap

Annual cashflow statement for Everest Medicines, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-215-5,658-1,009-247-844
Depreciation
Amortisation
Non-Cash Items545,088184-95166.5
Unusual Items
Other Non-Cash Items
Changes in Working Capital61.977.963.2-0.323-68
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-88.7-472-730-1,156-769
Capital Expenditures-93.3-520-976-433-266
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items45.90-5951,018
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-47.4-520-976-1,028752
Financing Cash Flow Items70.30-7.95
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities625,638-76.5-25.310.1
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-77.44,375-1,841-2,14932.3